2nd Quarter - Amendment
PHARMATHENE, INC for PHARMATHENE, INC
Firm
Client
Income
—
Expenses
$289,770
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2011 | $314,770 | Replaced |
| 2nd Quarter - Amendment (this page) | Jan 26, 2012 | $289,770 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization in House and Senate. FY-2012 Funding for Biomedical Advanced Research and Development Authority (BARDA) at HHS (Labor-HHS in Senate and House Appropriations). Education of Members of Congress and Staff on bioterroism threat.
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANCESCA COOK | Sr. VP Policy and Government Affairs |
| MARK EDWARD COOKE | Sr. Director Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.